当前位置:循环首页>正文

[ESH2010]高血压治疗的依从性——A.sharma教授专访

作者:  A.sharma   日期:2010/6/20 17:08:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

<International Circulation>: Management of obesity-related hypertension is a hot research area and most studies focus on pharmacotherapy and bariatric surgery. Can you tell us about some of the progress in this area and discuss treatment adherence in those patients?

  《国际循环》:降压治疗的依从性对于高血压患者的心血管保护作用非常重要。在某些患者,治疗依从性差与多种因素有关,除了应用合适的药物和教育患者正确服药以外,医生还有很多工作要做,您怎么看这个问题?

    <International Circulation>:  Adherence is of very important for the protection of hypertension patients, some patients’ lower treatment adherence is related to more factors, and more work is needed for doctors; this includes not only right instruction but also the right drugs, is that correct?
 

    Sharma教授:正如我刚才所讲到的,当我们谈到肥胖相关的高血压时,通常是指容量依赖性高血压,已经证实在此种情况下有RAAS激活。因此,对于合并超重/肥胖的高血压患者,利尿剂与RAAS阻断药物(ACEI或ARB)联用可能是最佳治疗方案。

    Prof. Sharma:So as I mentioned when you talk about obesity-related hypertension you are often talking about hypertension that is volume-dependent albeit we have shown that there is activation of the renin-angiotensin system and so using drugs that block both the renin-angiotensin system like ACE inhibitors or ARBS in combination with diuretics are probably the best anti-hypertensive combination for patients with overweight and obesity presenting with high blood pressure.

上一页  [1]  [2]  [3]  [4]  下一页

版面编辑:沈会会  责任编辑:张衡



高血压Navigator肥胖治疗依从性A.sharma

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530